Results

eNauka >  Rezultati >  Clinical outcomes of patients with lower risk myelodysplastic syndrome from EUMDS registry eligible for transplantation: Implications for transplantation strategies
Naziv: Clinical outcomes of patients with lower risk myelodysplastic syndrome from EUMDS registry eligible for transplantation: Implications for transplantation strategies
Autori Savic, Aleksandar  ; ...; (broj, koautora 21)
Godina: 2026
Publikacija: BRITISH JOURNAL OF HAEMATOLOGY
ISSN: 0007-1048 British Journal of Haematology Pretraži identifikator
Izdavač: Oxford : Wiley-Blackwell
Tip rezultata: Naučni članak
DOI: 10.1111/bjh.70384
WoS-ID: 001693810100001
PMID: 41704134
URI: https://enauka.gov.rs/handle/123456789/1031834
Projekat: Janssen Pharmaceutica
Amgen Limited
Novartis Pharmacy B.V. Oncology Europe
Takeda Pharmaceuticals International
European Union's Horizon 2020 research and innovation program [634789]
Gilead Sciences Inc.
Bristol-Myers Squibb/Celgene International
Lumanity RWE Limited
Izvor metapodataka: (Preuzeto iz Nasi u WoS)
Napomena: Online ahead of print.
M-kategorija: 
21M21 - Vodeći međunarodni časopis kategorije M21

Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.